| 1. |
- Carpentier, Camille, et al.
(författare)
-
Reinterpreting the relationship between number of species and number of links connects community structure and stability
- 2021
-
Ingår i: Nature Ecology & Evolution. - : Springer Nature. - 2397-334X. ; 5:8, s. 1102-1109
-
Tidskriftsartikel (refereegranskat)abstract
- For 50 years, ecologists have examined how the number of interactions (links) scales with the number of species in ecological networks. Here, we show that the way the number of links varies when species are sequentially removed from a community is fully defined by a single parameter identifiable from empirical data. We mathematically demonstrate that this parameter is network-specific and connects local stability and robustness, establishing a formal connection between community structure and two prime stability concepts. Importantly, this connection highlights a local stability-robustness trade-off, which is stronger in mutualistic than in trophic networks. Analysis of 435 empirical networks confirmed these results. We finally show how our network-specific approach relates to the classical across-network approach found in literature. Taken together, our results elucidate one of the intricate relationships between network structure and stability in community networks. This paper demonstrates that the scaling relationship between the number of species and the number of interactions (links) in a network can explain its local stability and robustness to secondary extinctions.
|
|
| 2. |
- De Laender, Frederik, et al.
(författare)
-
Mean species responses predict effects of environmental change on coexistence
- 2023
-
Ingår i: Ecology Letters. - : WILEY. - 1461-023X .- 1461-0248. ; 26:9, s. 1535-1547
-
Tidskriftsartikel (refereegranskat)abstract
- Environmental change research is plagued by the curse of dimensionality: the number of communities at risk and the number of environmental drivers are both large. This raises the pressing question if a general understanding of ecological effects is achievable. Here, we show evidence that this is indeed possible. Using theoretical and simulation-based evidence for bi- and tritrophic communities, we show that environmental change effects on coexistence are proportional to mean species responses and depend on how trophic levels on average interact prior to environmental change. We then benchmark our findings using relevant cases of environmental change, showing that means of temperature optima and of species sensitivities to pollution predict concomitant effects on coexistence. Finally, we demonstrate how to apply our theory to the analysis of field data, finding support for effects of land use change on coexistence in natural invertebrate communities.
|
|
| 3. |
- Devos, David, et al.
(författare)
-
Trial of Deferiprone in Parkinson’s Disease
- 2022
-
Ingår i: New England Journal of Medicine. - : Massachusetts Medical Society. - 0028-4793 .- 1533-4406. ; 387:22, s. 2045-2055
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUNDIron content is increased in the substantia nigra of persons with Parkinson's disease and may contribute to the pathophysiology of the disorder. Early research suggests that the iron chelator deferiprone can reduce nigrostriatal iron content in persons with Parkinson's disease, but its effects on disease progression are unclear.METHODSWe conducted a multicenter, phase 2, randomized, double-blind trial involving participants with newly diagnosed Parkinson's disease who had never received levodopa. Participants were assigned (in a 1:1 ratio) to receive oral deferiprone at a dose of 15 mg per kilogram of body weight twice daily or matched placebo for 36 weeks. Dopaminergic therapy was withheld unless deemed necessary for symptom control. The primary outcome was the change in the total score on the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS; range, 0 to 260, with higher scores indicating more severe impairment) at 36 weeks. Secondary and exploratory clinical outcomes at up to 40 weeks included measures of motor and nonmotor disability. Brain iron content measured with the use of magnetic resonance imaging was also an exploratory outcome.RESULTSA total of 372 participants were enrolled; 186 were assigned to receive deferiprone and 186 to receive placebo. Progression of symptoms led to the initiation of dopaminergic therapy in 22.0% of the participants in the deferiprone group and 2.7% of those in the placebo group. The mean MDS-UPDRS total score at baseline was 34.3 in the deferiprone group and 33.2 in the placebo group and increased (worsened) by 15.6 points and 6.3 points, respectively (difference, 9.3 points; 95% confidence interval, 6.3 to 12.2; P<0.001). Nigrostriatal iron content decreased more in the deferiprone group than in the placebo group. The main serious adverse events with deferiprone were agranulocytosis in 2 participants and neutropenia in 3 participants.CONCLUSIONSIn participants with early Parkinson's disease who had never received levodopa and in whom treatment with dopaminergic medications was not planned, deferiprone was associated with worse scores in measures of parkinsonism than those with placebo over a period of 36 weeks.
|
|
